From: HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan
Primary Site | II stage | III stage | IV stage | Male | Female | Total |
---|---|---|---|---|---|---|
Oropharyngeal cancer | 10 (28.6%) | 19 (54.3%) | 6 (17.1%) | 25 (71.4%) | 10 (28.6%) | 35 (46.1%) |
Tonsillar | 5 | 10 | 3 | 13 | 5 | 18 (51.4%) |
Base of tongue | 3 | 3 | 0 | 4 | 2 | 6 (17.1%) |
Other | 2 | 6 | 3 | 8 | 3 | 11 (31.4%) |
Oral cavity cancer | 12 (29.3%) | 25 (61.0%) | 4 (9.8%) | 25 (61%) | 16 (39%) | 41 (53.9%) |
Floor of mouth | 5 | 6 | 2 | 10 | 3 | 13 (31.7%) |
Tongue | 5 | 16 | 2 | 14 | 9 | 23 (56.1%) |
Buccal mucosa | 1 | 1 | 0 | 0 | 2 | 2 (4.9%) |
Alveolar ridge, retromolar trigone | 1 | 2 | 0 | 1 | 2 | 3 (7.3%) |